US Biological Data Visualization Market To Reach $569.1 Million by 2035

US biological data visualization market was valued at $239.0 million in 2025 and is projected to reach $569.1 million by 2035, growing at a CAGR of 9.1% from 2026 to 2035, according to a new report by OMR Global. Large, federally supported genomic data programs in the US are creating vast, diverse datasets that research institutions and clinicians rely on for advanced analysis and interpretation. The NIH All of Us Research Program is building one of the most extensive biomedical data resources in the world by collecting genomic, clinical, and health information from hundreds of thousands of participants. This ongoing effort generates multi?dimensional data that require robust visualization and analysis platforms to support precision medicine research, drug discovery, and disease understanding. Access to these datasets through cloud?based analysis tools directly increases demand for biological data visualization solutions capable of handling large?scale genomic and health data.

Browse the full report description of “US Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals and Clinics) Forecast Period 2026-2035” of https://www.omrglobal.com/industry-reports/us-biological-data-visualization-market

The scale of data emerging from these initiatives underscores their impact on US biological data analytics. As of early 2024, the All of Us Research Program’s Researcher Workbench includes data drawn from nearly 250,000 whole?genome sequences, contributing more than 275 million previously unreported genetic variants available for exploration by registered researchers. The program has enrolled over 750,000 participants, with plans to reach at least 1 million individuals, each contributing genomic, electronic health record, wearable device, and survey data. These rich datasets are curated in a cloud environment that supports integrated analysis and visualization workflows, reinforcing the need for advanced visualization tools in genomics research and health data interpretation.

Strategic Expansions and Innovations Strengthen US Multiomics and Spatial Biology Capabilities

• In October 2025, Illumina, Inc. launched BioInsight, a new business unit delivering advanced multiomic data analysis solutions. By integrating sequencing, data analytics, software, and AI, BioInsight supports researchers and pharmaceutical companies in identifying drug targets, understanding biological pathways, uncovering disease mechanisms, and generating actionable biological insights.

• In May 2024, Bruker Corporation acquired NanoString Technologies’ business for approximately $392.6 million in cash, including key product lines such as nCounter, GeoMx, CosMx, and AtoMx. Based in Seattle, NanoString specializes in spatial transcriptomics and gene expression analysis.

• In October 2024, Bruker established Bruker Spatial Biology, consolidating NanoString Technologies, Canopy Biosciences, and Bruker Spatial Genomics (formerly Acuity Spatial Genomics) to provide an integrated portfolio of spatial biology solutions.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Technique
  • Application
  • End-User
• Competitive Landscape – Agilent Technologies, Inc., GE HealthCare Technologies Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

US Biological Data Visualization Market Report Segment

By Technique

• Magnetic Resonance Imaging
• Microscopy
• Sequencing
• Others

By Application

• Genomic Analysis
• Cell Biology
• Molecular and Structural Analysis
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Hospitals and Clinics

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-biological-data-visualization-market